Cross-linked high amylose starch derivatives for drug release. II. Swelling properties and mechanistic study.
Acetate (Ac-), aminoethyl (AE-), and carboxymethyl (CM-) high amylose starch cross-linked 6 (HASCL-6) derivatives were previously shown to control the release of drugs over 20 h from monolithic tablets highly loaded (up to 60% drug). This report describes the swelling characteristics, which allow a better understanding of the mechanisms involved in the control of the drug release from the said polymeric matrices. The tablet swelling of HASCL-6, Ac-HASCL-6, and AE-HASCL-6 was found to not be affected by the ionic strength and by the pH between 1.2 (gastric) and 7 (intestinal), whereas the swelling of CM-HASCL-6 was shown to depend on both ionic strength and pH of the release medium. For all the studied polymers the drug loading did not change the equilibrium swelling ratio but affected the initial swelling velocity, seemingly due to the competition between drug and polymer for water uptake, a phenomenon probably influenced by the loading and the drug solubility. It was also shown that the increase of ionic strength would slightly increase the drug release time probably by decreasing the amount of free water still available to solubilize the drug present into the matrix.
Mulhbacher
Jérôme
J
Department of Chemistry and Biochemistry, Université du Québec à Montréal, CP 8888, Succ. A, Montréal, Qué., Canada H3C 3P8.
Ispas-Szabo
Pompilia
P
Mateescu
Mircea Alexandru
MA
D000082:Acetaminophen / Q000008:administration & dosage / Q000737:chemistry; D000688:Amylose / Q000031:analogs & derivatives* / Q000737:chemistry*; D003692:Delayed-Action Preparations; D006863:Hydrogen-Ion Concentration; D009994:Osmolar Concentration; D012995:Solubility; D013607:Tablets; D014527:Uric Acid / Q000008:administration & dosage / Q000737:chemistry
D003692:Delayed-Action Preparations; D013607:Tablets; D014527:Uric Acid; D000082:Acetaminophen; D000688:Amylose